Management of mild hidradenitis suppurativa: our greatest challenge yet.
作者信息
van der Zee H H, van de Bunte M, van Straalen K R
机构信息
Erasmus University Medical Center Rotterdam, Department of Dermatology, Rotterdam, the Netherlands.
Chairperson, Dutch Hidradenitis Patient Association (Hidradenitis Patiënten Vereniging, HPV), Apeldoorn, the Netherlands.
出版信息
Br J Dermatol. 2022 Feb;186(2):355-356. doi: 10.1111/bjd.20780. Epub 2021 Nov 15.
Abstract
摘要
相似文献
1
Management of mild hidradenitis suppurativa: our greatest challenge yet.
Br J Dermatol. 2022 Feb;186(2):355-356. doi: 10.1111/bjd.20780. Epub 2021 Nov 15.
2
Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4.
Dermatology. 2024;240(3):514-516. doi: 10.1159/000535867. Epub 2023 Dec 20.
3
Hidradenitis suppurativa: Impact of the French guidelines on dermatology practices.
Ann Dermatol Venereol. 2023 Sep;150(3):227-229. doi: 10.1016/j.annder.2022.09.008. Epub 2023 Mar 7.
4
Development of a clinical Scandinavian registry for hidradenitis suppurativa; HISREG.
Acta Derm Venereol. 2013 May;93(3):350-1. doi: 10.2340/00015555-1468.
5
Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group.
Acta Derm Venereol. 2017 Mar 10;97(3):412-413. doi: 10.2340/00015555-2513.
6
Hidradenitis Suppurativa: A Case Study.
J Pediatr Health Care. 2015 Jul-Aug;29(4):364-70. doi: 10.1016/j.pedhc.2014.11.011. Epub 2015 Jan 6.
7
Medical therapy is the optimal treatment for hidradenitis suppurativa.
J Am Acad Dermatol. 2020 Sep;83(3):977-978. doi: 10.1016/j.jaad.2020.02.078. Epub 2020 May 20.
8
Surgery is an essential aspect of managing patients with hidradenitis suppurativa.
J Am Acad Dermatol. 2020 Sep;83(3):979-980. doi: 10.1016/j.jaad.2020.03.008. Epub 2020 Apr 22.
9
Results from the Treatment of Hidradenitis Suppurativa Evaluation Study (THESEUS).
Br J Dermatol. 2024 Feb 16;190(3):e33. doi: 10.1093/bjd/ljae028.
10
Interactive, Proof of Concept Clinical Trial Design in Hidradenitis Suppurativa.
J Invest Dermatol. 2021 Feb;141(2):431-433. doi: 10.1016/j.jid.2020.06.006. Epub 2020 Jun 22.
引用本文的文献
1
Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators.
Int J Mol Sci. 2023 Apr 9;24(8):6969. doi: 10.3390/ijms24086969.
本文引用的文献
1
A narrative review of the definition of 'flare' in hidradenitis suppurativa.
Br J Dermatol. 2020 Jan;182(1):24-28. doi: 10.1111/bjd.18035. Epub 2019 Jul 28.
2
Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
Br J Dermatol. 2019 May;180(5):1214-1220. doi: 10.1111/bjd.17508. Epub 2019 Feb 25.
3
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
Br J Dermatol. 2017 Nov;177(5):1401-1409. doi: 10.1111/bjd.15748. Epub 2017 Oct 30.
4
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44. doi: 10.1111/jdv.12966. Epub 2015 Jan 30.
5
Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Br J Dermatol. 2014 Dec;171(6):1434-42. doi: 10.1111/bjd.13270. Epub 2014 Nov 11.
Zotero 插件